Background: No comprehensive study exists about mechanical thrombectomy accessibility for patients admitted to a primary stroke center without onsite interventional neuroradiology service.
Introduction
A recent meta-analysis from clinical trials has confirmed the clinical benefit of mechanical thrombectomy (MT) 1 in selected patients with acute ischemic stroke (AIS) and proximal artery occlusion and indicated that the transfer of patients from a primary stroke center (PSC) to a comprehensive stroke center (CSC) for rescue thrombectomy is a valid option. However, the treatment benefit decreases when reperfusion time is delayed 1,2 and consequently, new territorial stroke networks have to be organized to facilitate and speed up the implementation of reperfusion therapy. To our knowledge, no comprehensive study including all consecutive eligible patients in a comprehensive, real-life, monocentric cohort from a PSC has been performed. Therefore, it is crucial to identify relevant criteria (patient load and achievable time metrics) that might allow delivering MT in the shortest period of time. The aim of this study was to assess the accessibility to MT within 6 h for patients with AIS and large artery occlusion after transfer from a PSC to a distant CSC (156 km apart; 1.5 h by car).
Methods

Geographical considerations and transfer of selected patients
Perpignan General Hospital (Perpignan-GH) is 156 km away from the closest regional CSC in Montpellier that has a state-of-the-art interventional neuroradiology service (supporting information Figure S1 ). Since 2010, selected patients with AIS and intracranial large artery occlusion are transferred from Perpignan-GH to Montpellier for MT (pre-defined criteria in the online supporting information Table S1 ).
Study design
From the 1 January 2012 to 31 December 2014, the clinical data of all patients with AIS admitted to the Perpignan-GH PSC within 4.5 h from symptom onset were extracted from a prospectively maintained database and included in this comprehensive observational study. The evaluated parameters are listed in supporting information Table S1.
Statistical analysis
Data were presented using medians, interquartile ranges (IQR), means, and standard deviations (SD). Significance threshold was set at 5% and was calculated using the 2 and Student's t-tests.
Results
During the study period, among the 2701 patients with AIS admitted to the PSC, 385 (14.3%) were considered as potentially eligible for IVT and/or MT. Time of flight MRA indicated the presence of a proximal intracranial arterial occlusion in 211 of these patients (54.8%) among whom 119 were transferred (transfer rate ¼ 56.4%) ( Table 1 and supporting information Figure S2 ).
On arrival at the CSC, 60/119 patients (50.4%) underwent a second MRI. The rate of transfer without MT was 56.3% (n ¼ 67/119) and the main reason (46.2% of transfers without MT) was post-IVT clinical or imaging improvement at the CSC. Fifty-two patients underwent MT (24.6% of the 211 eligible patients) among whom 38 had a TICI score 2b-3. This corresponded to a reperfusion rate of 73.1% for MT-treated patients (n ¼ 52) and to a reperfusion (TICI score of 2b/ 3) by MT for 18% of all eligible patients (n ¼ 211).
Overall, patients received intravenous thrombolysis (IVT) within 3 h from symptom onset (median time: 175 min, IQR: 75) and mechanical recanalization occurred almost 7 h after symptoms (median time: 417 min, IQR: 124) (for details, see Table 1 ).
At the three-month follow-up, the rate of favorable outcome (mRS: 0-2) was not significantly different among patients eligible for MT, transferred patients ( 2 ¼ 0.03; p ¼ 0.9), and patients who received MT ( 2 ¼ 0.92; p ¼ 0.4) (supporting information Figure S3 ).
Discussion
Our results suggest that poor accessibility to MT, related to delayed transfers, is correlated with a low overall reperfusion rate. Indeed, despite the good reperfusion rate (73.1%) in patients who underwent MT, only 18% of all potential MT candidates were effectively recanalized by MT. Retrospectively, we identified a group of 73 patients (34.6% of all eligible patients) who could have benefited from MT in the presence of an interventional neuroradiology service at the PSC. This group included 47 patients (22.3%) who were not transferred due to inappropriate time window or unavailable transportation and 26 patients (12.3%) whose transfer was posteriorly defined as unnecessary due to delayed time window for MT or neurological worsening during transfer (Table 1) . Thus, we consider that in our setting, about one-third of patients had an obvious loss of chance due to unpredictable and uncontrollable factors. On the other hand, workflow improvements might help reducing the door-to-needle and the PSC door-in to door-out times (86 and 111 min, respectively), but with a limited impact, because very few centers using MRI have reached a door-to-needle time lower than 60 min, to date. 3 Prabhakaran et al. 4 suggested that increased delays in inter-hospital transfers can reduce the likelihood of performing angiography, with a 2.5% decrease in the chance of performing intra-arterial therapy for every minute lost in transfer time. The Perpignan-GH extensive rural catchment area and the very distant CSC may explain the substantial time differences with another comparable study in an urban setting (294 vs. 240 min for symptom onset to CSC door time). 5 Accordingly, the proportion of patients outside the treatment time International Journal of Stroke, 12 (5) window or with clinical/MRI worsening on arrival at the CSC also was higher in our study (24% vs. 2% and 15% vs. 8%, respectively). The main qualitative result is the extremely delayed time from symptom onset to reperfusion (about 7 h). However, patients treated beyond the 6-h time window were mostly selected on the basis of penumbral imaging patterns that could be used to identify low progressor profiles. Therefore, patients finally treated with MT might represent a low progressor subgroup who could benefit from delayed reperfusion at a distant CSC.
Conclusion
Our experience could be useful for establishing new facilities and networks to ensure MT accessibility to all eligible patients with AIS. Stroke networks often centralize endovascular AIS therapy in larger CSCs. 6 However, the benefits of such centralized care must be weighed against the risks related to longer transport times. According to our experience, transfer to a distant CSC offers effective mechanical recanalization only to a minority of slow progressor patients. Geographical considerations and PSC volume are the main reasons advocated to convert a PSC with a large population catchment area in a CSC that can deliver both thrombolysis and endovascular therapy.
